Rockefeller Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$227M Buy
643,944
+1,783
+0.3% +$636K 0.4% 43
2025
Q4
$210M Buy
642,161
+138,577
+28% +$44M 0.38% 43
2025
Q3
$142M Sell
503,584
-28,646
-5% -$8.31M 0.28% 67
2025
Q2
$149M Buy
532,230
+34,559
+7% +$9.79M 0.33% 55
2025
Q1
$155M Buy
497,671
+45,815
+10% +$13.5M 0.38% 41
2024
Q4
$118M Sell
451,856
-734
-0.2% -$218K 0.31% 63
2024
Q3
$146M Buy
452,590
+4,901
+1% +$1.6M 0.39% 47
2024
Q2
$140M Buy
447,689
+14,718
+3% +$4.32M 0.4% 44
2024
Q1
$123M Sell
432,971
-183,549
-30% -$53.7M 0.36% 58
2023
Q4
$178M Buy
616,520
+111,373
+22% +$30.3M 0.59% 26
2023
Q3
$136M Buy
505,147
+237,408
+89% +$59.2M 0.52% 27
2023
Q2
$59.1M Buy
267,739
+6,634
+3% +$1.54M 0.23% 103
2023
Q1
$63.1M Sell
261,105
-15,150
-5% -$3.72M 0.27% 90
2022
Q4
$72.6M Sell
276,255
-7,570
-3% -$2.03M 0.36% 61
2022
Q3
$64M Buy
283,825
+78,035
+38% +$18.9M 0.33% 74
2022
Q2
$50.1M Buy
205,790
+10,402
+5% +$2.55M 0.27% 84
2022
Q1
$47.2M Buy
195,388
+18,500
+10% +$4.25M 0.23% 103
2021
Q4
$39.8M Buy
176,888
+20,704
+13% +$4.37M 0.19% 130
2021
Q3
$33.2M Buy
156,184
+16,291
+12% +$3.75M 0.17% 140
2021
Q2
$34.1M Buy
139,893
+15,496
+12% +$3.81M 0.19% 129
2021
Q1
$30.9M Buy
124,397
+12,204
+11% +$2.91M 0.21% 121
2020
Q4
$25.8M Buy
112,193
+25,935
+30% +$5.98M 0.2% 127
2020
Q3
$21.9M Buy
86,258
+10,240
+13% +$2.54M 0.21% 116
2020
Q2
$17.9M Buy
76,018
+3,654
+5% +$834K 0.19% 125
2020
Q1
$14.7M Buy
72,364
+6,861
+10% +$1.5M 0.19% 115
2019
Q4
$15.8M Buy
65,503
+29,622
+83% +$6.53M 0.2% 112
2019
Q3
$6.94M Buy
35,881
+11,382
+46% +$2.18M 0.09% 157
2019
Q2
$4.51M Buy
24,499
+10,336
+73% +$1.85M 0.06% 172
2019
Q1
$2.69M Buy
14,163
+12,396
+702% +$2.37M 0.04% 221
2018
Q4
$345K Buy
1,767
+60
+4% +$11.7K 0.01% 360
2018
Q3
$354K Hold
1,707
0.01% 306
2018
Q2
$315K Buy
1,707
+15
+0.9% +$2.65K 0.01% 301
2018
Q1
$289K Buy
+1,692
New +$311K ﹤0.01% 304

Other funds holding AMGN

Rockefeller Capital Management's AMGN Position: Q1 2026 in Review

Rockefeller Capital Management increased its Amgen (AMGN) stake by 0.28% in Q1 2026, buying an estimated $636K and bringing the position to 643,944 shares worth $227M. The position accounts for 0.4% of the portfolio, ranked #43.

Rockefeller Capital Management first reported a position in AMGN in Q1 2018 and has held it in 33 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Rockefeller Capital Management held 643,944 shares of Amgen worth $227M as of Q1 2026.
  • Rockefeller Capital Management bought 1,783 Amgen shares in Q1 2026, an estimated $636K.
  • Amgen made up 0.4% of Rockefeller Capital Management's portfolio in Q1 2026, its #43 holding.
  • Rockefeller Capital Management first reported a position in Amgen in Q1 2018 and has held it in 33 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.